Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Sep 24 | FBRX Forte Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 7.07 | 2,000 | 14.14 k | 2,000 |
14 Feb 24 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 14,200 | 130.36 k | 14,200 |
3 Jan 24 | ONCT Oncternal Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.4961 | 8,868 | 4.40 k | 140,922 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 210,000 | 65.10 k | 210,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 28,750 | 8.91 k | 28,750 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 109,597 | 33.98 k | 109,597 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 280,000 | 86.80 k | 280,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 35,120 | 10.89 k | 35,120 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 75,000 | 23.25 k | 75,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.96 | 210,000 | 201.60 k | 0 |